CK
STJ

Cohen Klingenstein’s St Jude Medical STJ Stock Holding History

Cohen Klingenstein’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,260
Closed -$662K – 163
2016
Q4 		$662K Hold
8,260
– – 0.11% 111
2016
Q3 		$659K Hold
8,260
– – 0.11% 104
2016
Q2 		$644K Hold
8,260
– – 0.12% 106
2016
Q1 		$454K Sell
8,260
-600
-7% -$32.7K 0.09% 127
2015
Q4 		$547K Hold
8,860
– – 0.1% 114
2015
Q3 		$559K Hold
8,860
– – 0.11% 109
2015
Q2 		$647K Hold
8,860
– – 0.12% 110
2015
Q1 		$579K Sell
8,860
-30
-0.3% -$2K 0.11% 113
2014
Q4 		$578K Hold
8,890
– – 0.11% 112
2014
Q3 		$535K Hold
8,890
– – 0.09% 118
2014
Q2 		$616K Hold
8,890
– – 0.12% 106
2014
Q1 		$581K Hold
8,890
– – 0.12% 111
2013
Q4 		$551K Hold
8,890
– – 0.11% 115
2013
Q3 		$477K Hold
8,890
– – 0.1% 120
2013
Q2 		$406K Buy
+8,890
New +$385K 0.09% 126

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Cohen Klingenstein's STJ Position: Q1 2017 in Review

Cohen Klingenstein sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 8,260 shares — an estimated $662K sold.

Cohen Klingenstein first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $662K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Cohen Klingenstein reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Cohen Klingenstein sold 8,260 St Jude Medical shares in Q1 2017, an estimated $662K.
  • Cohen Klingenstein first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Cohen Klingenstein's St Jude Medical position peaked at $662K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Cohen Klingenstein's 13F filing for Q1 2017, filed 13 Apr 2017.